|
1
|
Hynes RO, Marcantonio EE, Stepp MA, Urry
LA and Yee GH: Integrin heterodimer and receptor complexity in
avian and mammalian cells. J Cell Biol. 109:409–420. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Labat-Robert J: Cell-Matrix interactions:
the role of fibronectin and integrins. A survey. Pathol Biol
(Paris). 60:15–19. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang JL, Wang JL, Gao N, Chen ZT, Tian YP
and An J: Up-regulated expression of beta3 integrin induced by
dengue virus serotype 2 infection associated with virus entry into
human dermal microvascular endothelial cells. Biochem Biophys Res
Commun. 356:763–768. 2007. View Article : Google Scholar
|
|
4
|
Huo T, Du X, Zhang S, Liu X and Li X:
Gd-EDDA/HYNIC-RGD as an MR molecular probe imaging integrin
alphanubeta3 receptor-expressed tumor-MR molecular imaging of
angiogenesis. Eur J Radiol. 73:420–427. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Reardon DA, Neyns B, Weller M, Tonn JC,
Nabors LB and Stupp R: Cilengitide: an RGD pentapeptide ανβ3 and
ανβ5 integrin inhibitor in development for glioblastoma and other
malignancies. Future Oncol. 7:339–354. 2011.
|
|
6
|
Brooks PC, Clark RF and Cheresh DA:
Requirement of vascular integrin alpha ν beta 3 for angiogenesis.
Science. 264:569–571. 1994.
|
|
7
|
Dalmas Wilk DA, Scicchitano MS and Morel
D: In vitro investigation of integrin-receptor antagonist-induced
vascular toxicity in the mouse. Toxicol In Vitro. 27:272–281.
2013.PubMed/NCBI
|
|
8
|
Lark MW, Stroup GB, Dodds RA, et al:
Antagonism of the osteoclast vitronectin receptor with an orally
active nonpeptide inhibitor prevents cancellous bone loss in the
ovariectomized rat. J Bone Miner Res. 16:319–327. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miller WH, Alberts DP, Bhatnagar PK, et
al: The discovery of orally active nonpeptide vitronectin receptor
antagonists based on a 2-benzazepine Gly-Asp mimetic. J Med Chem.
43:22–26. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Badger AM, Blake S, Kapadia R, et al:
Disease-modifying activity of SB-273005, an orally active,
nonpeptide alphaνbeta3 (vitronectin receptor) antagonist, in rat
adjuvant-induced arthritis. Arthritis Rheum. 44:128–137.
2001.PubMed/NCBI
|
|
11
|
Gomes N, Vassy J, Lebos C, et al: Breast
adenocarcinoma cell adhesion to the vascular subendothelium in
whole blood and under flow conditions: effects of alphavbeta3 and
alphaIIbbeta3 antagonists. Clin Exp Metastasis. 21:553–561. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang S and Liu G: Effects of ανβ3 integrin
antagonist SB-273005 resisting to embryo implantation in mouse.
Journal of Sun Yat-sen University (Medical Sciences). 29:439–443.
2008.(In Chinese).
|
|
13
|
van Mourik MS, Macklon NS and Heijnen CJ:
Embryonic implantation: cytokines, adhesion molecules, and immune
cells in establishing an implantation environment. J Leukoc Biol.
85:4–19. 2009.PubMed/NCBI
|
|
14
|
Bridges GA, Day ML, Geary TW and Cruppe
LH: Triennial Reproduction Symposium: deficiencies in the uterine
environment and failure to support embryonic development. J Anim
Sci. 91:3002–3013. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu C, Wang J, Zhou S, Wang B and Ma X:
Association between -238 but not -308 polymorphism of Tumor
necrosis factor alpha (TNF-alpha)v and unexplained recurrent
spontaneous abortion (URSA) in Chinese population. Reprod Biol
Endocrinol. 8:1142010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cerkiene Z, Eidukaite A and Usoniene A:
Immune factors in human embryo culture and their significance.
Medicina (Kaunas). 46:233–239. 2010.PubMed/NCBI
|
|
17
|
Yang KM, Ntrivalas E, Cho HJ, et al: Women
with multiple implantation failures and recurrent pregnancy losses
have increased peripheral blood T cell activation. Am J Reprod
Immunol. 63:370–378. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Strober W: Immunology: The expanding T(H)2
universe. Nature. 463:434–435. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Raghupathy R: Pregnancy: success and
failure within the Th1/Th2/Th3 paradigm. Semin Immunol. 13:219–227.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Saito S, Shima T, Inada K and Nakashima A:
Which types of regulatory T cells play important roles in
implantation and pregnancy maintenance? Am J Reprod Immunol.
69:340–345. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fukuda MN and Sugihara K: Cell adhesion
molecules in human embryo implantation. Sheng Li Xue Bao.
64:247–258. 2012.PubMed/NCBI
|
|
22
|
Li TC, Makris M, Tomsu M, Tuckerman E and
Laird S: Recurrent miscarriage: aetiology, management and
prognosis. Hum Reprod Update. 8:463–481. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jin LP, Fan DX, Zhang T, et al: The
costimulatory signal upregulation is associated with Th1 bias at
the maternal-fetal interface in human miscarriage. Am J Reprod
Immunol. 66:270–278. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bix M, Kim S and Rao A: Immunology.
Opposites attract in differentiating T cells. Science.
308:1563–1565. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luppi P: How immune mechanisms are
affected by pregnancy. Vaccine. 21:3352–3357. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lunghi L, Ferretti ME, Medici S, Biondi C
and Vesce F: Control of human trophoblast function. Reprod Biol and
Endocrinol. 5:62007. View Article : Google Scholar
|
|
27
|
Saito S, Nakashima A, Shima T and Ito M:
Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J
Reprod Immunol. 63:601–610. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Saini V, Arora S, Yadav A and
Bhattacharjee J: Cytokines in recurrent pregnancy loss. Clin Chim
Acta. 412:702–708. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Aluvihare VR, Kallikourdis M and Betz AG:
Tolerance, suppression and the fetal allograft. J Mol Med (Berl).
83:88–96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Biedermann T, Röcken M and Carballido JM:
TH1 and TH2 lymphocyte development and regulation of TH
cell-mediated immune responses of the skin. J Investig Dermatol
Symp Proc. 9:5–14. 2004. View Article : Google Scholar : PubMed/NCBI
|
